ABVC News and Press, ABVC BioPharma Inc. From 12/10/21

Shares of ABVC Biopharma (ABVC +11.8%) are higher after the company yesterday announced a dietary supplement distribution deal and an analyst today wrote a favorable report. ABVC's BioKey subsidiary is in a a three-year distribution deal with Taiwan-based Define Biotech. Zacks Small Cap Resea...

Gainers: Petros Pharmaceuticals (NASDAQ:PTPI) +37%, Biofrontera BFRI +20%, ABVC BioPharma (NASDAQ:ABVC) +12%, Halozyme Therapeutics (NASDAQ:HALO) +11%, Context Therapeutics CNTX +9%. Losers: Angion Biomedica (NASDAQ:ANGN) -22%, Ensysce Biosciences ...

ABVC Biopharma's (ABVC +2.5%) subsidiary BioKey launches dietary supplements derived from the maitake mushroom in both tablet and liquid forms. The company notes beta-glucans in maitake mushrooms have been found to reduce cholesterol, resulting in improved artery functionality and overall bet...

Fremont, CA - ( NewMediaWire ) - December 09, 2021 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that BioKey, a wholly-owned subsidiary of the Company based in...

ABVC BioPharma (NASDAQ:ABVC): Q3 GAAP EPS of -$0.07. Revenue of $98,999 vs. $115,553 in 3Q20. Press Release For further details see: ABVC BioPharma reports Q3 results

FREMONT, CA, Nov. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (Nasdaq: ABVC), a biotechnology company specializing in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes, today announced its financial and op...

FREMONT, CA, Nov. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc.(Nasdaq: ABVC), a biotechnology company specializing in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes, today announced the receipt of $4,245...

ABVC BioPharma (ABVC -23.0%), a clinical-stage biopharma company based in Fremont, California, once surged over 900% in the pre-market to end the week among the top three micro-cap stocks in the healthcare sector. While online chatter fueled its meteoric rise, Seeking Alpha users pounced...

After a massive 137% rise yesterday, shares of ABVC Biopharma (ABVC -33.1%) have pared some of those gains today. Shares were up 400% premarket yesterday due to strong retail investor interest on the trading social network StockTwits. Volume so far today is ~4.5M shares. Average daily volume ...

Gainers: The OLB OLB +145%. Avis Budget CAR +84%. Xcel Brands (NASDAQ:XELB) +30%. Navitas Semiconductor (NYSE:NVTS) +30%. Rogers ROG +30%. SilverBox (NASDAQ:SBEAU) +24%. Esports (NASDAQ:GMBL) +19%. Arista Networks ANET +19%. Kiniksa KNSA +18%. DZS DZSI +17%. Lose...